In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, INmune Bio Inc (NASDAQ: INMB) closed at $385.71K up 1493506% from its previous closing price of $7.24. In other words, the price has increased by $1493506 from its previous closing price. On the day, 1.49 million shares were traded. INMB stock price reached its highest trading level at $7.48 during the session, while it also had its lowest trading level at $6.1605.
Ratios:
For a deeper understanding of INmune Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on January 28, 2025, initiated with a Buy rating and assigned the stock a target price of $23.
On October 21, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $20.
On September 27, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $18.Raymond James initiated its Outperform rating on September 27, 2024, with a $18 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 30 ’24 when Moss David J bought 10,000 shares for $5.29 per share. The transaction valued at 52,868 led to the insider holds 1,285,869 shares of the business.
Tesi Raymond Joseph bought 15,380 shares of INMB for $98,048 on Sep 12 ’24. The President and CEO now owns 1,554,106 shares after completing the transaction at $6.38 per share. On Sep 12 ’24, another insider, Moss David J, who serves as the Chief Financial Officer of the company, bought 7,690 shares for $6.38 each. As a result, the insider paid 49,024 and bolstered with 1,275,869 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 149163120 and an Enterprise Value of 129092208. For the stock, the TTM Price-to-Sale (P/S) ratio is 2961.60 while its Price-to-Book (P/B) ratio in mrq is 4.93. Its current Enterprise Value per Revenue stands at 2581.844.
Stock Price History:
The Beta on a monthly basis for INMB is 1.57, which has changed by -0.15272242 over the last 52 weeks, in comparison to a change of 0.09544468 over the same period for the S&P500. Over the past 52 weeks, INMB has reached a high of $10.50, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is -15.16%, while the 200-Day Moving Average is calculated to be -4.98%.
Shares Statistics:
For the past three months, INMB has traded an average of 385.71K shares per day and 913420 over the past ten days. A total of 22.93M shares are outstanding, with a floating share count of 16.50M. Insiders hold about 28.90% of the company’s shares, while institutions hold 25.53% stake in the company. Shares short for INMB as of 1748563200 were 6179710 with a Short Ratio of 16.02, compared to 1745971200 on 5827472. Therefore, it implies a Short% of Shares Outstanding of 6179710 and a Short% of Float of 33.07.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
